Nuclear Radiology: Page 12

RadioMedix, Curium win FDA clearance for Detectnet

By AuntMinnie.com staff writers

Biotechnology firm RadioMedix and global nuclear medicine firm Curium have received U.S. Food and Drug Administration (FDA) clearance for their Detectnet PET diagnostic radiopharmaceutical copper-64 DOTATATE.

September 7, 2020

Nuclear medicine volume plummets due to COVID-19

By Rebekah Moan

It's no secret COVID-19 has disrupted nuclear medicine clinical practice, research, and work environments. However, a new survey by the Society of Nuclear Medicine and Molecular Imaging quantifies the effects: nearly 80% of respondents saw declines of 50% to 75% in non-PET nuclear medicine procedures.

September 7, 2020

U.S. government awards SNMMI $750K grant

By AuntMinnie.com staff writers

The U.S. Department of Energy's National Nuclear Security Administration (NNSA) awarded the Society of Nuclear Medicine and Molecular Imaging (SNMMI) a grant for $750,000 over three years to support nuclear medicine initiatives in sub-Saharan Africa.

July 30, 2020

SNMMI 2020: AI analysis of PET could help classify prostate cancer

By Erik L. Ridley

An artificial intelligence (AI) algorithm may be able to assist in classifying prostate lesions on 3D prostate-specific membrane antigen-PET exams, according to research presented at the annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI).

July 16, 2020

SNMMI 2020: PSMA-PET/CT changes prostate cancer management

By Kate Madden Yee

PET/CT imaging with an F-18 DCFPyL prostate-specific membrane antigen (PSMA) radiopharmaceutical changed prostate cancer management in two-thirds of cases, according to research presented July 13 at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2020 virtual annual meeting.

July 14, 2020

SNMMI taps leaders for 2020-2021 year

By AuntMinnie.com staff writers

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has tapped its leadership slate for the 2020-2021 year at this week's virtual conference.

July 13, 2020

SNMMI 2020: How nuclear medicine handled COVID-19

By Wayne Forrest

Implementing a proactive, multipronged strategy to combat the COVID-19 pandemic helped Mount Sinai Hospital safeguard its patients and staff as much as humanly possible, according to a Monday presentation at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2020 virtual annual meeting.

July 13, 2020

SNMMI 2020: Medical students key to the specialty's future

By Wayne Forrest

The early recruitment of medical students into nuclear medicine and molecular imaging is the key to the specialty's future, said Dr. Vasken Dilsizian during his president's address on Sunday at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) virtual annual meeting.

July 12, 2020

CereHealth highlights population template at SNMMI 2020

By AuntMinnie.com staff writers

Artificial intelligence software developer CereHealth will present study data on a population template for CereMetrix, the company's brain SPECT imaging software, at the virtual 2020 Society of Nuclear Medicine and Molecular Imaging (SNMMI) conference.

July 9, 2020

Lantheus to discuss PyL imaging agent at SNMMI 2020

By AuntMinnie.com staff writers

Lantheus Medical Imaging will showcase the potential of its PyL (F-18 DCFPyL) radiopharmaceutical at the virtual Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2020 annual meeting, July 11-14.

June 30, 2020

JNM releases COVID-19 content in June issue

By AuntMinnie.com staff writers

The Journal of Nuclear Medicine (JNM) has released its June issue, which includes five new articles and commentaries related to COVID-19.

June 10, 2020

Curium files for approvals of germanium-68 tracer

By AuntMinnie.com staff writers

Nuclear medicine firm Curium has filed regulatory applications in the U.S. and Europe for germanium-68, a radiopharmaceutical used in PET imaging.

June 8, 2020

Previous Page

Page 12 of 81

Next Page